IRD Opus Genetics trades modestly higher post Q4 2025 earnings despite wider than expected per share losses State Street SPDR SP Biotech ETF XBI Investment Case Analysis and Peer Benchmarking for 2026 CEPU Cent Puerto reports steep Q4 2024 earnings miss as shares post a small gain today